BOCHK Asset Management’s Merck MRK Stock Holding History

BOCHK Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.7M	Buy	44,360 +30,860	+229%	+$3.61M	0.9%	34
2026 Q1	$1.62M	Sell	13,500 -4,500	-25%	-$520K	0.34%	70
2025 Q4	$1.89M	Buy	+18,000	New	+$1.69M	0.51%	19
2025 Q2	–	Sell	-1,787	Closed	-$160K	–	64
2025 Q1	$160K	Buy	+1,787	New	+$167K	0.09%	41

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BOCHK Asset Management's MRK Position: Q2 2026 in Review

BOCHK Asset Management increased its Merck (MRK) stake by 229% in Q2 2026, buying an estimated $3.61M and bringing the position to 44,360 shares worth $5.7M. The position accounts for 0.9% of the portfolio, ranked #34.

BOCHK Asset Management first reported a position in MRK in Q1 2025 and has held it in 4 quarters since. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

BOCHK Asset Management held 44,360 shares of Merck worth $5.7M as of Q2 2026.
BOCHK Asset Management bought 30,860 Merck shares in Q2 2026, an estimated $3.61M.
Merck made up 0.9% of BOCHK Asset Management's portfolio in Q2 2026, its #34 holding.
BOCHK Asset Management first reported a position in Merck in Q1 2025 and has held it in 4 quarters since.
3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BOCHK Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.